NCT00118144 2014-08-21Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung CancerNational Cancer Institute (NCI)Phase 2 Completed42 enrolled 7 charts
NCT00117351 2011-02-17VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC FeaturesMillennium Pharmaceuticals, Inc.Phase 2 Terminated